GLP-1s Explained · formblends network
Every GLP-1 and GIP/GLP-1 agent, one page each.
An encyclopedia of incretin drugs: semaglutide, tirzepatide, liraglutide, dulaglutide, exenatide, lixisenatide, retatrutide, orforglipron, survodutide, CagriSema, mazdutide and oral semaglutide. Mechanism, approval dates, label dosing, pivotal trial numbers and side-effect rates from the label.
- Calculators
- 0
- Guides
- 0
In preparation
GLP-1s Explained is being written.
An encyclopedia of incretin drugs: semaglutide, tirzepatide, liraglutide, dulaglutide, exenatide, lixisenatide, retatrutide, orforglipron, survodutide, CagriSema, mazdutide and oral semaglutide. Mechanism, approval dates, label dosing, pivotal trial numbers and side-effect rates from the label. The first guides and tools publish here soon. Until then, the FormBlends network already covers the ground below.
From the FormBlends network
Sister sites
- FormBlends Research · Trial digests with the numbers left in.
- The Science · Mechanism explainers with original diagrams.
- Semaglutide Hub · Ozempic, Wegovy, Rybelsus and compounded semaglutide, by the label and by the numbers.
- Tirzepatide Hub · Titration dates, vial units, missed doses and self-pay costs for tirzepatide, with the label and trial numbers behind each one.